• General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

News

Article

Understanding the Role of Micronutrients in Vitiligo

Key Takeaways

  • Vitiligo affects 1% of the global population, with triggers including stress, sunburn, and trauma, often impairing quality of life.
  • Zinc and copper are crucial for melanin production and immune health, with studies showing reduced serum levels in vitiligo patients.
SHOW MORE

Studies show conflicting serum levels of zinc and copper in vitiligo patients, indicating a need for further research.

Patient with vitiligo | Image Credit: © Tetiana - stock.adobe.com

Image Credit: © Tetiana - stock.adobe.com

Affecting approximately 1% of the global population, vitiligo transcends ethnicities, genders, and skin types, although its visibility is more pronounced in individuals with darker skin due to the contrast.1 Despite its long-standing recognition, vitiligo remains stigmatized, often impairing patients' quality of life. Emotional stress, sunburn, major illnesses, surgical procedures, and physical trauma are frequently cited triggers.Notably, over half of patients develop vitiligo before the age of 20, and late-onset cases raise concerns about potential co-morbid autoimmune disorders such as thyroid dysfunction and diabetes.2

Role of Micronutrients in Vitiligo

Zinc (Zn), Copper (Cu), and Selenium (Se) are essential micronutrients that play crucial roles in various physiological processes, including immunity, inflammation, and oxidative stress regulation.3 Zn is a co-factor for numerous enzymes and transcription factors, while Cu is integral to enzymatic functions associated with melanogenesis, the process of melanin production. Se, present in several seleno-proteins, contributes to immune system function and antioxidant defense.

Normal Zn levels range from 70 to 180 µg per 100 ml, with a recommended daily allowance of 8 mg for women and 11 mg for men. Zn is vital for melanin synthesis and immune health. Supplementation has shown promise as an adjuvant treatment for vitiligo, with studies indicating that Zn can help mitigate apoptotic processes and promote melanogenesis.3 However, findings on serum Zn levels in vitiligo patients are inconsistent, with some studies reporting reduced levels, while others associate higher Zn levels with an increased risk of vitiligo.4,5

Several studies have reported decreased serum Cu levels in vitiligo patients, reinforcing the notion that Cu is essential for maintaining normal pigmentation.6 However, like Zn, the data surrounding Cu levels in relation to vitiligo is conflicting, necessitating further investigation.5

Se’s involvement in the pathogenesis of vitiligo is linked to its role in redox regulation and antioxidant defense via glutathione peroxidase. While some studies report low selenium levels in vitiligo patients, others suggest elevated levels.4,7 This variability underscores the need for comprehensive analysis to clarify the micronutrient's role in vitiligo.

Analysis Overview

A recent systematic review and meta-analysis aimed to evaluate the serum levels of Zn, Cu and Se in individuals with vitiligo. This study adhered to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines and involved a rigorous search through databases like PubMed and Google Scholar.8

The meta-analysis included studies from 1970 to 2022, focusing on case-control studies comparing serum micronutrient levels in diagnosed vitiligo patients with healthy controls. A total of 41 studies encompassing 3,353 vitiligo cases and 10,638 controls were analyzed. Statistical assessments were conducted to evaluate the association between micronutrient levels and vitiligo.

Results

  • Zn Levels: Among the 27 studies analyzed, there was a significant decline in serum Zn levels in vitiligo patients compared to controls (SMD = -0.86; P < 0.0001).
  • Cu Levels: Analysis of 23 studies showed a significant reduction in serum Cu levels in vitiligo patients (SMD = -0.50; P < 0.0001).
  • Se Levels: Among 12 studies, findings indicated a slightly elevated Se level in vitiligo patients, especially within Asian populations, suggesting a potential racial predisposition affecting the micronutrient's role in vitiligo pathogenesis.

Researchers behind the analysis believe the complex interplay between oxidative stress and trace elements such as Zn, Cu, and Seis central to understanding vitiligo’s pathogenesis. Oxidative stress can induce cellular damage, potentially exacerbating melanocyte loss. They stated the relationship between serum micronutrient levels and vitiligo remains inconclusive, particularly regardingSe, which exhibits variability across different populations.

The meta-analysis represents1 of the largest investigations into the serum levels of these micronutrients in relation to vitiligo, offering insights into their potential roles in treatment strategies. However, researchers stated the contradictory nature of existing studies highlights the necessity for further research to establish definitive connections and therapeutic implications.

Conclusion

Vitiligo’s pathogenesis is multifactorial, involving oxidative stress and the interplay of essential micronutrients. Researchers noted the decline in serum levels of Zn and Cu in vitiligo patients compared to healthy controls emphasizes the potential role of these trace elements in disease management. Although serum Se levels presented mixed results, particularly in Asian populations, the analysis stated that further investigation is warranted to explore the therapeutic potential of micronutrient supplementation in vitiligo treatment. Continued research will aid in refining treatment strategies and improving patient outcomes for this often-debilitating condition.

References

  1. Frisoli ML, Essien K, Harris JE. Vitiligo: Mechanisms of pathogenesis and treatment. Annu Rev Immunol. 2020;38:621-648. doi:10.1146/annurev-immunol-100919-023531
  2. Stojanovich L, Marisavljevich D. Stress as a trigger of autoimmune disease. Autoimmun Rev. 2008;7(3):209-213. doi:10.1016/j.autrev.2007.11.007
  3. Sanad EM, El-Fallah AA, Al-Doori AR, et al. Serum zinc and inflammatory cytokines in vitiligo. J Clin Aesthet Dermatol. 2020;13(12 Suppl 1):S29-S33.
  4. Beazley WD, Gaze D, Panske A, Panzig E, Schallreuter KU. Serum selenium levels and blood glutathione peroxidase activities in vitiligo. Br J Dermatol. 1999;141(2):301-303. doi:10.1046/j.1365-2133.1999.02980.x
  5. Wang XH, Chen XD. The zinc and copper levels in serum of 48 vitiligo patients. J Nantong Med. Coll 16, 277. 1996.
  6. Genov D, Bozhkov B, Zlatkov NB. Copper pathochemistry in vitiligo. Clin Chim Acta. 1972;37:207-211. doi:10.1016/0009-8981(72)90435-4
  7. Wacewicz M, Socha K, Soroczyńska J, et al. Selenium, zinc, copper, Cu/Zn ratio and total antioxidant status in the serum of vitiligo patients treated by narrow-band ultraviolet-B phototherapy. J Dermatolog Treat. 2018;29(2):190-195. doi:10.1080/09546634.2017.1357797
  8. Anam K, Ananyan S, Rishabh M, et al. Zinc, copper, and selenium levels in vitiligo: a systematic review and meta-analysis. Sci Rep. 2024;14(1):23700. Published 2024 Oct 10. doi:10.1038/s41598-024-61982-8
Related Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Andrew Alexis, MD, MPH, an expert on vitiligo
Andrew Alexis, MD, MPH, an expert on vitiligo
Andrew Alexis, MD, MPH, an expert on vitiligo
© 2024 MJH Life Sciences

All rights reserved.